Perceived helpfulness of treatment for specific phobia: Findings from the World Mental Health Surveys.

Cross-Sectional Studies Health Surveys Humans Mental Disorders Patient Acceptance of Health Care Phobic Disorders / therapy Retrospective Studies Surveys and Questionnaires
Helpfulness of treatment Simple phobia Specific phobia World Mental Health Surveys

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 06 2021
Historique:
received: 11 03 2021
revised: 05 04 2021
accepted: 07 04 2021
pubmed: 4 5 2021
medline: 6 7 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Although randomized trials show that specific phobia treatments can be effective, it is unclear whether patients experience treatment as helpful in clinical practice. We investigated this issue by assessing perceived treatment helpfulness for specific phobia in a cross-national epidemiological survey. Cross-sectional population-based WHO World Mental Health (WMH) surveys in 24 countries (n=112,507) assessed lifetime specific phobia. Respondents who met lifetime criteria were asked whether they ever received treatment they considered helpful and the number of professionals seen up to the time of receiving helpful treatment. Discrete-event survival analysis was used to calculate conditional-cumulative probabilities of obtaining helpful treatment across number of professionals seen and of persisting in help-seeking after prior unhelpful treatment. 23.0% of respondents reported receiving helpful treatment from the first professional seen, whereas cumulative probability of receiving helpful treatment was 85.7% after seeing up to 9 professionals. However, only 14.7% of patients persisted in seeing up to 9 professionals, resulting in the proportion of patients ever receiving helpful treatment (47.5%) being much lower than it could have been with persistence in help-seeking. Few predictors were found either of perceived helpfulness or of persistence in help-seeking after earlier unhelpful treatments. Retrospective recall and lack of information about either types of treatments received or objective symptomatic improvements limit results. Despite these limitations, results suggest that helpfulness of specific phobia treatment could be increased, perhaps substantially, by increasing patient persistence in help-seeking after earlier unhelpful treatments. Improved understanding is needed of barriers to help-seeking persistence.

Sections du résumé

BACKGROUND
Although randomized trials show that specific phobia treatments can be effective, it is unclear whether patients experience treatment as helpful in clinical practice. We investigated this issue by assessing perceived treatment helpfulness for specific phobia in a cross-national epidemiological survey.
METHODS
Cross-sectional population-based WHO World Mental Health (WMH) surveys in 24 countries (n=112,507) assessed lifetime specific phobia. Respondents who met lifetime criteria were asked whether they ever received treatment they considered helpful and the number of professionals seen up to the time of receiving helpful treatment. Discrete-event survival analysis was used to calculate conditional-cumulative probabilities of obtaining helpful treatment across number of professionals seen and of persisting in help-seeking after prior unhelpful treatment.
RESULTS
23.0% of respondents reported receiving helpful treatment from the first professional seen, whereas cumulative probability of receiving helpful treatment was 85.7% after seeing up to 9 professionals. However, only 14.7% of patients persisted in seeing up to 9 professionals, resulting in the proportion of patients ever receiving helpful treatment (47.5%) being much lower than it could have been with persistence in help-seeking. Few predictors were found either of perceived helpfulness or of persistence in help-seeking after earlier unhelpful treatments.
LIMITATIONS
Retrospective recall and lack of information about either types of treatments received or objective symptomatic improvements limit results.
CONCLUSIONS
Despite these limitations, results suggest that helpfulness of specific phobia treatment could be increased, perhaps substantially, by increasing patient persistence in help-seeking after earlier unhelpful treatments. Improved understanding is needed of barriers to help-seeking persistence.

Identifiants

DOI: 10.1016/j.jad.2021.04.001 PMID: 33940429 PMC: PMC8154701
pubmed: 33940429
pii: S0165-0327(21)00325-6
doi: 10.1016/j.jad.2021.04.001
pmc: PMC8154701
mid: NIHMS1696799
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-209

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH060220
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Psychol Med. 2017 Jul;47(10):1744-1760
pubmed: 28222820
Int J Methods Psychiatr Res. 2006;15(4):167-80
pubmed: 17266013
JAMA Psychiatry. 2020 Aug 1;77(8):830-841
pubmed: 32432716
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Br J Psychiatry. 2019 Jan;214(1):4-10
pubmed: 29952277
Epidemiol Psychiatr Sci. 2020 Aug 12;29:e153
pubmed: 32782057
Arch Psychiatr Nurs. 2014 Feb;28(1):43-9
pubmed: 24506986
J Clin Psychol. 2011 Dec;67(12):1197-209
pubmed: 22105535
Psychol Med. 2010 Jun;40(6):899-909
pubmed: 19719899
Depress Anxiety. 2016 Jul;33(7):667-75
pubmed: 26990012
Psychosomatics. 2007 Mar-Apr;48(2):123-7
pubmed: 17329605
Br J Psychiatry. 2008 May;192(5):368-75
pubmed: 18450663
Am J Psychiatry. 2002 May;159(5):845-51
pubmed: 11986140
Depress Anxiety. 2018 Mar;35(3):195-208
pubmed: 29356216
Int J Environ Res Public Health. 2020 Mar 15;17(6):
pubmed: 32183487
J Consult Clin Psychol. 1993 Dec;61(6):952-65
pubmed: 8113496
Br J Psychiatry. 2017 Feb;210(2):119-124
pubmed: 27908899
Behav Ther. 2008 Sep;39(3):207-23
pubmed: 18721635
BMC Med. 2019 May 24;17(1):101
pubmed: 31122269
Arch Gen Psychiatry. 2005 Jun;62(6):629-40
pubmed: 15939840
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
World Psychiatry. 2019 Oct;18(3):276-285
pubmed: 31496102
JAMA Psychiatry. 2014 Mar;71(3):273-80
pubmed: 24402003
Psychiatr Serv. 2015 Oct;66(10):1064-73
pubmed: 26073408
Clin Psychol Rev. 2008 Jul;28(6):1021-37
pubmed: 18410984
Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):340-6
pubmed: 25959110
Psychiatr Serv. 2013 Oct;64(10):981-9
pubmed: 23820725
World J Biol Psychiatry. 2008;9(4):248-312
pubmed: 18949648
Clin Psychol Rev. 2007 Apr;27(3):266-86
pubmed: 17112646

Auteurs

Ymkje Anna de Vries (YA)

Department of Developmental Psychology, University of Groningen, Groningen, the Netherlands; Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, Groningen, the Netherlands.

Meredith G Harris (MG)

School of Public Health, The University of Queensland, Herston, QLD 4006, Australia; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, QLD 4072, Australia.

Daniel Vigo (D)

Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Wai Tat Chiu (WT)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Nancy A Sampson (NA)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.

Ali Al-Hamzawi (A)

College of Medicine, Al-Qadisiya University, Diwaniya governorate, Iraq.

Jordi Alonso (J)

Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain; Pompeu Fabra University (UPF), Barcelona, Spain.

Laura H Andrade (LH)

Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brazil; Section of Psychiatric Epidemiology - LIM 23, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.

Corina Benjet (C)

Department of Epidemiologic and Psychosocial Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Ronny Bruffaerts (R)

Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.

Brendan Bunting (B)

School of Psychology, Ulster University, Londonderry, United Kingdom.

José Miguel Caldas de Almeida (JM)

Lisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.

Giovanni de Girolamo (G)

IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Silvia Florescu (S)

National School of Public Health, Management and Development, Bucharest, Romania.

Oye Gureje (O)

Department of Psychiatry, University College Hospital, Ibadan, Nigeria.

Josep Maria Haro (JM)

Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain; Department of Psychology, College of Education, King Saud University, Riyadh, Saudi Arabia.

Chiyi Hu (C)

Shenzhen Institute of Mental Health & Shenzhen Kangning Hospital, Shenzhen, China.

Elie G Karam (EG)

Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Balamand University, Faculty of Medicine, Beirut, Lebanon; Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon.

Norito Kawakami (N)

Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan.

Viviane Kovess-Masfety (V)

Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057, Paris Descartes University, Paris, France.

Sing Lee (S)

Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.

Jacek Moskalewicz (J)

Institute of Psychiatry and Neurology, Warsaw, Poland.

Fernando Navarro-Mateu (F)

UDIF-SM, Servicio Murciano de Salud. IMIB-Arrixaca. CIBERESP-Murcia, Región de Murcia, Spain.

Akin Ojagbemi (A)

Department of Psychiatry, University of Ibadan, Nigeria.

José Posada-Villa (J)

Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia (Cundinamarca University, calle 28 # 5B 02, Bogotá, 11001000 (zip), Colombia.

Kate Scott (K)

Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand.

Yolanda Torres (Y)

Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia.

Zahari Zarkov (Z)

Department of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.

Andrew Nierenberg (A)

Dauten Family Center for Bipolar Treatment Innovation, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. Electronic address: kessler@hcp.med.harvard.edu.

Peter de Jonge (P)

Department of Developmental Psychology, University of Groningen, Groningen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Perceived helpfulness of treatment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Perceived helpfulness of treatment for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Perceived helpfulness of treatment for...
questionsmedicales.fr › Troubles mentaux › Perceived helpfulness of treatment for...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Adhésion et observance thérapeutiques › Acceptation des soins par les patients › Perceived helpfulness of treatment for...
questionsmedicales.fr › Troubles mentaux › Troubles anxieux › Troubles phobiques › Perceived helpfulness of treatment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Perceived helpfulness of treatment for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Perceived helpfulness of treatment for...